Skip to content
Recall Observatory FDA recall evidence

Drug product

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

D-0432-2023

February 23, 2023

Class II

Product summary

Firm
The Harvard Drug Group
Event
Event 91751
Status
Terminated
Classification
Class II
Quantity
17,586 cartons
Official record key
drug-enforcement:D-0432-2023

Official wording

Reason: Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Code information: Lot: M04145 Exp. 01/2024

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Packaging defect